Literature DB >> 12927791

Specific alpha v integrin receptors modulate K1735 murine melanoma cell behavior.

Yongjian Yang1, Dongmin Dang, Amha Atakilit, Brian Schmidt, Joseph Regezi, Xiaowu Li, David Eisele, Duncan Ellis, Daniel M Ramos.   

Abstract

Expression of beta 3 integrins is increased in invasive melanoma. In this study we show that K1735 cell proliferation is enhanced by the expression of either beta 3 or a constitutively active Src. We investigated possible modulators of FN matrix assembly and found that matrix metalloproteinase 2 (MMP2) was activated by alpha v beta 3. alpha v beta 3 integrin was localized to focal contacts whereas alpha v beta 5 was peripherally distributed. MMP2 was also activated by expression of CASrc. MMP2 activation inversely correlated with FN matrix assembly, in that it dramatically reduced the organization of a FN matrix. K1735 cell migration on VN and invasion through a reconstituted basement membrane were decreased in the presence of anti-MMP2 antibodies. These results demonstrate that the expression of the alpha v beta 3 complex modulates melanoma cell behavior including activation of Src, organization of the cytoskeleton, assembly of the extracellular matrix, cell motility, and activation of MMP2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927791     DOI: 10.1016/s0006-291x(03)01477-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Role of integrins in regulating proteases to mediate extracellular matrix remodeling.

Authors:  Jiao Yue; Kun Zhang; Jianfeng Chen
Journal:  Cancer Microenviron       Date:  2012-03-22

2.  Specific amino acid restriction inhibits attachment and spreading of human melanoma via modulation of the integrin/focal adhesion kinase pathway and actin cytoskeleton remodeling.

Authors:  Ya-Min Fu; Hui Zhang; Mingjie Ding; Yi-Qi Li; Xing Fu; Zu-Xi Yu; Gary G Meadows
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

3.  Osteopontin is an endogenous modulator of the constitutively activated phenotype of pulmonary adventitial fibroblasts in hypoxic pulmonary hypertension.

Authors:  Adil Anwar; Min Li; Maria G Frid; Binod Kumar; Evgenia V Gerasimovskaya; Suzette R Riddle; B Alexandre McKeon; Roopa Thukaram; Barbara O Meyrick; Mehdi A Fini; Kurt R Stenmark
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-05-11       Impact factor: 5.464

4.  Tumor cell and carcinoma-associated fibroblast interaction regulates matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma.

Authors:  Alexandra Fullár; Ilona Kovalszky; Mario Bitsche; Angela Romani; Volker Hans Schartinger; Georg Mathias Sprinzl; Herbert Riechelmann; József Dudás
Journal:  Exp Cell Res       Date:  2012-04-01       Impact factor: 3.905

5.  A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.

Authors:  Helmut Friess; Jan M Langrehr; Helmut Oettle; Jochen Raedle; Marco Niedergethmann; Christian Dittrich; Dieter K Hossfeld; Herbert Stöger; Bart Neyns; Peter Herzog; Pascal Piedbois; Frank Dobrowolski; Werner Scheithauer; Robert Hawkins; Frieder Katz; Peter Balcke; Jan Vermorken; Simon van Belle; Neville Davidson; Albert Abad Esteve; Daniel Castellano; Jörg Kleeff; Adrien A Tempia-Caliera; Andreas Kovar; Johannes Nippgen
Journal:  BMC Cancer       Date:  2006-12-11       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.